Form D · Biotechnology
Nortis Inc
Woodinville, WA · CIK 0001416214
Offering snapshot reported Aug 10, 2022 · SEC filing
- Reported sold
- $6M Offering amount: $9.5M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 8, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 10, 2022 | Initial | $6,000,000 | No comparison | 3 | SEC filing |
| Jan 10, 2022 | Initial | $1,500,000 | No comparison | 2 | SEC filing |
| Jun 15, 2021 | Initial | $1,000,000 | No comparison | 3 | SEC filing |
| Jun 15, 2021 | Initial | $1,500,000 | No comparison | 3 | SEC filing |
| Jul 18, 2017 | Amendment | $323,200 | No comparison | 10 | SEC filing |
| Jun 30, 2017 | Amendment | $12,500 | No comparison | 1 | SEC filing |
| Aug 5, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jun 30, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Mar 19, 2015 | Initial | $408,845 | No comparison | 1 | SEC filing |
| Jul 7, 2014 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Mar 26, 2014 | Amendment | $1,242,250 | $814,750vs Mar 27, 2013 | 22 | SEC filing |
| Mar 27, 2013 | Amendment | $427,500 | $417,500vs Mar 28, 2012 | 9 | SEC filing |
| Mar 28, 2012 | Initial | $10,000 | No comparison | 2 | SEC filing |
| Nov 18, 2011 | Initial | $15,000 | No comparison | 1 | SEC filing |
| Oct 27, 2009 | Initial | $13,000 | No comparison | 2 | SEC filing |
| Oct 19, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-455527
Source: Form D, filed Aug 10, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul Conley | Director |
| Greg Corona | Director |
| Sharon K. Everson | Director |
| Kriss Hammond | Director |
| Mary Ellen Harrison | Director |
| Alan C. Nelson | Director, Executive |
| Thomas Neumann | Director, Executive |
| Susan Preston | Director |
| Walter L. Robb | Director |
| Makoto Shintani | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
17280 Woodinville Redmond Road Ne Suite B 828
Woodinville, WA, 98072
Woodinville, WA, 98072